NAMS position history
The shares of Newamsterdam Pharma (NAMS) that MAVERICK CAPITAL LTD reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q4: 350,005 shares, $9M, 0.16% of portfolio, New
- 2025 Q1: 549,469 shares, $11M, 0.20% of portfolio, Add +57.0%
- 2025 Q2: 1,531,874 shares, $28M, 0.42% of portfolio, Add +178.8%
- 2025 Q3: 1,504,747 shares, $43M, 0.57% of portfolio, Reduce −1.8%
- 2025 Q4: 1,894,226 shares, $66M, 0.71% of portfolio, Add +25.9%
- 2026 Q1: 2,186,402 shares, $70M, 0.81% of portfolio, Add +15.4%
- 2026 Q2: 3,267,802 shares, $111M, 0.98% of portfolio, Add +49.5%
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|